Sign In
Buy GNNSF
$3.08
+0.150 (+5.12%)
At Close: Aug 10, 2026
Add GNNSF to Watchlist?
Some Reasons Why To Add GNNSF:
- Healthy interest coverage ratio of 31.5x
- +67.4% YTD performance
- Low bankruptcy risk (Altman Z-Score: 5.48)
Notice: Technical analysis is hidden due to insufficient data.
There can be multiple reasons for our algorithm to not provide conclusion. One of them can be low or no liquidity.
If you think this is not correct, please
GNNSF Performance
GNNSF Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jun 05, 2017 | Jun 05, 2017 | Jun 21, 2017 | $0.0015 | 0% |
FAQ
What is the symbol for Genscript Biotech Corporation Stock and on which exchange is it traded?
The symbol for Genscript Biotech Corporation is GNNSF and it is traded on the OTCMKTS (OTC Markets Group).
Should I buy or sell Genscript Biotech Corporation Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Genscript Biotech Corporation (GNNSF) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Jan 13, 2026, the price has risen 67.39%. The current 3-month trend forecast projects a rise of 19.58%.
How to buy Genscript Biotech Corporation Stock?
Genscript Biotech Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Genscript Biotech Corporation Stock.
Click here for our free guide on how to buy Genscript Biotech Corporation Stock.
What's the current price of Genscript Biotech Corporation Stock?
As of the end of day on the Aug 10, 2026, the price of an Genscript Biotech Corporation (GNNSF) share was $3.08.
What is the 52-week high and low for Genscript Biotech Corporation Stock?
The 52-week high for Genscript Biotech Corporation Stock is $3.08 and the 52-week low is $1.30.
What is the market capitalization of Genscript Biotech Corporation Stock?
As of the Aug 10, 2026, the market capitalization of Genscript Biotech Corporation is 6.729B.
When is the next earnings date for Genscript Biotech Corporation?
The upcoming earnings date for Genscript Biotech Corporation is Aug 15, 2026.
